Chemoinformaics analysis of Propanoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester
| Molecular Weight | 228.332 | nRot | 3 |
| Heavy Atom Molecular Weight | 204.14 | nRig | 7 |
| Exact Molecular Weight | 228.173 | nRing | 1 |
| Solubility: LogS | -2.125 | nHRing | 0 |
| Solubility: LogP | 2.507 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 40.119 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.751 |
| Synth | 3.939 |
| Natural Product Likeliness | 1.104 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.017 |
| HIA | 0.006 |
| CACO-2 | -4.523 |
| MDCK | 0.0000206 |
| BBB | 0.545 |
| PPB | 0.891406 |
| VDSS | 1.207 |
| FU | 0.0818337 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.382 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.426 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.61 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.307 |
| CL | 8.099 |
| T12 | 0.783 |
| hERG | 0.018 |
| Ames | 0.024 |
| ROA | 0.043 |
| SkinSen | 0.403 |
| Carcinogencity | 0.113 |
| EI | 0.836 |
| Respiratory | 0.737 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.810429 |